|Day Low/High||0.73 / 0.85|
|52 Wk Low/High||0.40 / 2.68|
Company Also Announces Agreement to Acquire Certain IP Assets of PCG Molecular, LLC
Company Inks Deal with Circle Care Management to Provide Genomic Services to Clients in Latin America
Expands genetic testing to include Molecular Microbiology, detecting multitude of organisms related to causes of bacterial vaginosis, candidiasis and STDs
Experienced Public Company Executive Joins Senior Management
Combination With AEON Clinical Laboratories Leverages Technology and Specialized Lab Testing Capabilities to Offer Innovative Healthcare Solutions
Poor Medication Compliance Costs the U.S. Healthcare System $100 Billion to $289 Billion Annually
Additional Financial Information to be Filed in Form 8-K Prior to Call
Regulation A+ and self-underwritten offerings may be the vehicles of choice for companies that can't afford a traditional IPO.
Proposed Combination With AEON Clinical Laboratories Progresses
Company Provides Update on Proposed Transaction With AEON Clinical Laboratories
Cancer Detect Profile is Now Available for Use by More Than 6,000 Doctors to Reach More Than One Million Patients
Initial Implementation of Our Telehealth-Based Mental Health and Rehab Treatment in 8 Clinics, Which Serve 80,000 Patients Annually
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.